McCormick & Company, Incorporated vs Regeneron Pharmaceuticals Inc — how do they compare? McCormick & Company, Incorporated trades at $52.01 (market cap $14.04B), while Regeneron Pharmaceuticals Inc trades at $680.5 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 5× McCormick & Company, Incorporated's market cap, and McCormick & Company, Incorporated pays the higher dividend (3.68%). Which is the better fit depends on your goals.
| MKC | REGN | |
|---|---|---|
Market Cap | $14.04B | $70.47B |
Sector | Consumer Staples | Health |
52-Week High | $72.81 | $812.27 |
52-Week Low | $45.60 | $545.46 |
Enterprise Value | $18.65B | $64.42B |
Dividend Yield | 3.68% | 0.56% |
Trailing returns across standard periods
Latest headlines on both assets
In its 130-year history, McCormick has grown to become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond end consumers, McCormick's customer base also includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers, with about 30% of sales generated beyond its home turf to include 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and the recently acquired Cholula brand.
Read more on MKC →Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →